Professor Mark Emberton

  • Qualifications
    BSc, MD, FRCS (Urol)
  • NHS Base
    University College London Hospitals NHS Trust, 235 Euston Road, London NW1 2BU
  • Speciality
  • Sub speciality
    Urological oncology
  • Year qualified
  • Consulting address
    London Urology Associates, 114a Harley Street, London W1G 7JL
  • Research interests
    Prostate disease (benign and malignant), the non invasive evaluation of men at risk of having prostate cancer, methodological aspects of clinical research, particularly the use of alternatives to the randomised control trial in surgery.
  • Languages
    English, Spanish (fluent)
  • Biography

    Professor Mark Emberton holds the post of professor in interventional oncology at University College London and is associate professor at Middlesex University, London. At UCLH he is pathway director for urological cancer for UCL Partners. He is also honorary clinical director of the Clinical Effectiveness Unit at the Royal College of Surgeons of England. Prof Emberton’s clinical and research interests are focused mainly on diseases of the prostate gland, both benign and malignant. In prostate cancer much of his activity is at present focused on evaluating minimally invasive therapies for localised prostate cancer.